6th Annual GCC Innovative Drug Discovery and Development Conference: Pioneering New Approaches for Healthcare Innovation

SwRI will be exhibiting at the 6th Annual GCC Innovative Drug Discovery and Development Conference.

Southwest Research Institute provides pharmaceutical development and bioengineering services for government and industry clients. Our expert staff support every phase of drug discovery through clinical trials and manufacturing in FDA-inspected CGMP facilities in San Antonio, Texas. SwRI’s facilities are supported by our Quality Management System to maintain ISO 13485 protocols.

SwRI will present the poster “Research and Development of Oxime OPNA Antidotes,” which details the Institute’s multiyear efforts to develop safe and scalable synthetic methods to supply gram to kilogram level quantities of Organophosphorus Nerve Agent (OPNA) Antidotes under CGMP in support of clinical development.

For more information, contact Tristan Adamson and Shawn Blumberg or visit Pharmaceutical Development and Drug Discovery.